Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro.

Published byMiriam Lapajne Modified over 5 years ago

Similar presentations

Presentation on theme: "Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro."— Presentation transcript:

1 Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro fertilization  Marc Germond, M.D., Paola Capelli, M.D., Giuliana Bruno, M.D., Sara Vesnaver, M.D., Alfred Senn, Ph.D., Nathalie Rouge, Pharm.D., Ph.D., J Biollaz, M.D.  Fertility and Sterility  Volume 77, Issue 2, Pages (February 2002) DOI: /S (01)02979-X

2 FIGURE 1 Progesterone plasma concentration after Ellios™ (n = 60, ▴) and Utrogestan™ (n = 63, •) administration. Broken and solid lines refer to nonpregnant and pregnant patients, respectively. Germond. Vaginal progesterone support and IVF. Fertil Steril 2002. Fertility and Sterility  , DOI: ( /S (01)02979-X)

Download ppt "Comparison of the efficacy and safety of two formulations of micronized progesterone (ellios™and utrogestan™) used as luteal phase support after in vitro."

Similar presentations

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.
Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection  Na Huang, M.S., Bing Situ, M.S., Xiao.

Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection  Na Huang, M.S., Bing Situ, M.S., Xiao.
Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during.

Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during.
Does Previous Salpingectomy Improve Implantation and Pregnancy Rates in Patients with Severe Tubal Factor Infertility who are Undergoing In Vitro Fertilization?

Does Previous Salpingectomy Improve Implantation and Pregnancy Rates in Patients with Severe Tubal Factor Infertility who are Undergoing In Vitro Fertilization?
Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women3  Howard Levine,

Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women3  Howard Levine,
Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation  Renato.

Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation  Renato.
Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.
Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates  Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.
Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States  Jennifer.

Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States  Jennifer.
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,

Follicular-phase ovarian follicular fluid and plasma cytokine profiling of natural cycle in vitro fertilization patients  N. Ellissa Baskind, M.B.Ch.B.,
Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program  Fady I Sharara, M.D.,

Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program  Fady I Sharara, M.D.,
Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age  Sanja Kupesic, M.D., Ph.D., Asim Kurjak,

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age  Sanja Kupesic, M.D., Ph.D., Asim Kurjak,
In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors  Ahmad O. Hammoud, M.D.,

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors  Ahmad O. Hammoud, M.D.,
Laura D. Almquist, M. D. , Creighton E. Likes, M. D

Laura D. Almquist, M. D. , Creighton E. Likes, M. D
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer  Renato Fanchin, M.D., Claudia Righini, M.D., Dominique.

Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer  Renato Fanchin, M.D., Claudia Righini, M.D., Dominique.
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.

Similar presentations

Ads by Google